ENDRA Life Sciences Inc. (NDRA)
5.94
0.08 (1.37%)
At close: Jan 15, 2025, 12:05 PM
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 |
| PE Ratio | -3.33K | -1.56K | -4.43K | -2.10K | -1.42K | -1.21K | -4.36K | -9.61K | -11.70K | -12.23K |
| PS Ratio | n/a | n/a | n/a | n/a | n/a | 1.92M | 66.69K | 51.72K | 18.91K | 47.67K |
| PB Ratio | 5.92K | 2.86K | 4.59K | 3.51K | 4.63K | 1.89K | 4.44K | -29.83K | 106.53K | 44.05K |
| P/FCF Ratio | -3.50K | -1.59K | -4.44K | -2.33K | -2.55K | -1.52K | -7.09K | -20.27K | -27.31K | -15.94K |
| P/OCF Ratio | -3.51K | -1.61K | -4.45K | -2.34K | -2.57K | -1.54K | -7.10K | -20.27K | -31.64K | -19.08K |
| OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | -1.25K | -9.39 | -2.55 | -0.6 | -2.5 |
| Debt / Equity Ratio | 0.07 | 0.08 | 0.06 | 0.10 | 0.15 | 0.00 | n/a | -1.06 | n/a | n/a |
| Quick Ratio | 3.36 | 3.45 | 7.00 | 7.73 | 3.10 | 7.07 | 6.71 | 0.11 | 0.12 | 1.69 |
| Current Ratio | 3.36 | 5.00 | 7.83 | 8.32 | 3.15 | 7.13 | 6.93 | 0.14 | 0.54 | 4.14 |
| Asset Turnover | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.06 | 1.05 | 2.90 | 0.80 |
| Interest Coverage | n/a | -611.04 | n/a | -49.49 | -4.6 | n/a | n/a | n/a | n/a | n/a |
| Return on Equity (ROE) | -1.78 | -1.83 | -1.04 | -1.67 | -3.27 | -1.57 | -1.02 | 3.11 | -9.11 | -3.6 |
| Return on Assets (ROA) | -1.49 | -1.42 | -0.87 | -1.37 | -2.17 | -1.36 | -0.88 | -5.66 | -4.68 | -3.1 |
| Return on Capital (ROIC) | -1.8 | -1.74 | -1.01 | -1.48 | -2.12 | -1.44 | -0.88 | 2.00 | -6.27 | -2.52 |
| Dividend Yield | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | n/a | n/a | n/a | n/a | n/a |
| Payout Ratio | -0.00 | -0.00 | -0.01 | -0.03 | -0.27 | n/a | n/a | n/a | n/a | n/a |
| Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | 100.00% | 50.86% | 54.25% | 52.75% | 53.67% |
| Net Profit Margin | n/a | n/a | n/a | n/a | n/a | -158.67K% | -1.53K% | -538.3% | -161.64% | -389.89% |
| Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | -158.67K% | -1.53K% | -538.3% | -161.64% | -389.89% |
| Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | -146.08K% | -1.32K% | -347.52% | -111.24% | -272.85% |
| FCF Margin | n/a | n/a | n/a | n/a | n/a | -126.38K% | -941% | -255.17% | -69.25% | -299.02% |
| EBITDA Margin | n/a | n/a | n/a | n/a | n/a | -146.08K% | -1.30K% | -334.93% | -106.12% | -266.19% |